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Immobilized carcinoembryonic antigen (CEA) and non-specific rossreacting antigen (NCA) bound 3 strains of E. coli of human origin. The binding 
was dose dependent, saturable, and of high avidity. Binding of the bacteria to CEA and NCA was completely abolished in the presence of 10 
mM a-methyl D-mannopyranoside. Bacteria did not bind to concanavalin A. In addition, binding to deglycosylated CEA was either absent or 
significantly reduced. These findings indicate that the E. coli strains bind to D-mannosyl residues in CEA and NCA. Considering the tissue distribu- 
tion of CEA (brush border of colonic epithelium) and NCA (granulocytes), these glycoproteins may be involved in the recognition of bacteria. 
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1. INTRODUCTION 
Carcinoembryonic antigen (CEA), a marker for 
human colorectal carcinomas, is a major glycoprotein 
of the glycocalyx of human colonic carcinoma cells [ 11. 
In normal colonic mucosa, the highest amounts of
CEA have been identified on the cells lining the luminal 
surface [2,3], CEA has been isolated from normal col- 
onic mucosa [4], from colon washings of healthy per- 
sons 151, and from the supernatant of organ cultures of 
normal colon mucosa [B]. Recently, several genes which 
are highly homologous to the CEA gene have been 
described [7,8], One of the genes codes for the ‘non- 
specific crossreacting antigen’, a glycoprotein which is 
actively produced by normal granulocytes [9-l 11. The 
CEA gene family is a member of the immunoglobulin 
supergene family [ 121. 
Here we present first data that E. coli of human 
origin binds to immobilized CEA and NCA. Since both 
the colonic epithelium and granulocytes are involved in 
the recognition of bacteria, bacterial recognition may 
be one of the biological functions of the family of CEA 
and related glycoproteins. 
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2. MATERIALS AND METHODS 
2.1. Strains and culture methods 
The E. coli strains were isolated from human feces (Ty 7717) and 
from tracheal secretions (Va 068/l, Va 084) and passaged on DST 
agar (Oxoid, Wesel, FRG) for 18 h at 37°C under aerobic conditions. 
Subsequently, binding and inhibition studies to CEA and NCA as 
well as first hemagglutination studies were performed. Two strains 
(Va 084 and Va 68/l) were further passaged in Luria broth for an ad- 
ditional 48 h at 37*C. Subsequently, hemagglutination assays were 
repeated. 
2.2. ~emaggluiination assay 
A hemagglutination test routinely used for the determination of 
mannose-sensitive or mannose-resistant hemagglutination was ap- 
plied using guinea pig erythrocytes. Agglutination of erythrocytes in 
the absence but not in the presence of 25 mM a-methyl D- 
mannopyranoside was defined as mannose-sensitive hemagglutina- 
tion [13]. 
2.3. Adhesion and inhibition assays 
Microtiter plates (Type Maxisorp, diameter per well: 7 mm; Nunc, 
Wiesbaden, FRG) were coated with 50 pl of solutions of either CEA, 
NCA, deglycosyfated CEA (amounts indicated in figure legends and 
table 1), or concanavalin A (10 mgll) in 0.2 M carbonate buffer, pH 
8.3, overnight at RT. CEA was purified as described 1141. N-terminal 
and internal amino acid sequences of the preparation have been 
published [12]. NCA was purified from human spleen by perchloric 
acid extraction and immunoabsorbent purification over the 
monoclonal anti-CEA antibody T84.1 [15,16]. The sequence of the 
24 N-terminal amino acids matches the sequence published for NCA 
[12]. The concentrations of CEA and NCA were determined by 
amino acid analysis. CEA was deglycosylated as described (121. The 
concentration of deglycosylated CEA used for coating was chosen to 
give signal intensities in enzyme immunoassays with monoclonal an- 
tibody T84.1 [IS] similar to native CEA. The concentrations refer to 
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the protein moieties of the antigens. Unspecific binding sites were 
blocked by a solution of 1% BSA in PBS (2 h, RT). Wells were wash- 
ed 3 times with PBS containing 0.05% Tween-20 (v/v). This solution 
was also used for subsequent washing steps. Bacteria were suspended 
in PBS and adjusted to a turbidity corresponding to 6 x lo*-2 x 10’ 
bacteria/ml. 150 pl of the suspension was added to the wells and in- 
cubated overnight at 4°C. For inhibition experiments with car- 
bohydrates (all from commercial sources), the bacterial suspension 
was centrifuged, the supernatant was discarded, and the bacteria 
were resuspended in PBS containing the appropriate concentrations 
of carbohydrates. 
2.4. Detection of attached bacteria 
Binding of attached bacteria was revealed by enzyme im- 
munoassays. For the detection of E. coli by antisera, a rabbit pool 
serum against Klebsiella pneumoniae crossreacting with E. coli 
(1: 100 in PBS) was used for strains Va 068/l and Ty 7717. This an- 
tiserum bound to the E. coli strains as shown by indirect im- 
munofluorescence microscopy. For strain Va 084, a homologous 
rabbit immune serum (1: 1500 in PBS) was applied. The adherent 
bacteria were incubated with the antisera for l-2 h at 37°C. After 
washing, wells were incubated with a goat anti-rabbit IgG washing, 
wells were incubated with a goat anti-rabbit IgG antiserum con- 
jugated to horseradish peroxidase at a dilution of 1: 250 in PBS (Bio- 
Rad, Miinchen, FRG) for 1 hat room temperature (100 &well). The 
color reaction was developed as described [17]. In control ex- 
periments, (i) immobilized glycoproteins, and (ii) bacteria were omit- 
ted. Background OD was <O.l with the homologous antiserum to 
strain Va 084, and in the range of 0.2-0.3 with the crossreacting pool 
antiserum in both controls. Background OD values were subtracted 
from the values obtained in the presence of attached bacteria. As ad- 
ditional detection method, bacteria attached to microtiter plates were 
stained with 50 ~1 per well of an Acridine orange solution (Api Bio 
Merieux, Niirtingen, FRG) for 30 min, washed and examined for 
bacteria in an UV inverted microscope. 
3. RESULTS 
3.1. Binding of E. coli to CEA and NCA 
Three different strains of E. coli were tested with 
respect o the adhesion to immobilized CEA and NCA. 
Each strain adhered to CEA and NCA. An example for 
the binding of strain Va 084 to CEA as revealed by the 
Acridine orange stain is given in fig.la. As shown in 
fig.2, the binding of the different strains increases with 
increasing amounts of immobilized CEA. Binding 
plateaus are reached at CEA amounts of approximately 
100 ng added per well. With NCA binding of strain 
Va 084 reached a plateau at about 300 ng antigen add- 
ed per well (fig.3). Binding of the remaining strains was 
tested at constant amounts of NCA (250 ng added per 
well). For both strains, OD values of >0.5 were obtain- 
ed after subtraction of background staining. In order to 
exclude that mannosyl residues on the bacteria may 
bind to CEA or NCA, or that trace amounts of con- 
canavalin A (ConA) in the CEA preparation are 
responsible for the binding activity, control ex- 
periments were performed with immobilized ConA 
(500 ng per well). Since ConA bound antibodies, bin- 
ding of bacteria was determined microscopically using 
the Acridine orange stain (cf. fig.1). No binding could 
be detected. 
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Fig. 1. Binding of E. coli strain Va 084 to CEA absorbed to microtiter 
plates in the presence of different amounts of cu-methyl D- 
mannopyranoside. Acridine orange stain (250 ng CEA per well). 
Concentrations of a-methyl D-mannopyranoside: (a) 0.2 mmol/l; (b) 
1.6 mmol/l; at concentrations of > 10 mmol/l, binding was 
completely inhibited. x 947. 
3.2. Inhibition studies 
The different strains of E. coli were added to im- 
mobilized CEA or NCA in the presence of increasing 
amounts of a-methyl D-mannopyranoside. The effect 
was monitored by enzyme immunoassay and by direct 
staining of the attached bacteria. For each strain, the 
binding to CEA was completely abolished at 10 mM cy- 
methyl D-mannopyranoside (fig.4). For strain Va 084, 
the corresponding Acridine orange stain is shown in 
fig.lb. The binding of strain Va 084 to NCA was 
0 100 200 300 400 
CEA [ng added per well] 
Fig.2. Binding of different strains of E. coli to CEA absorbed to 
microtiter plates. Wells were coated with CEA amounts indicated on 
the abscissa. The absorbance was read at 492 nm. The values refer to 
the difference of the absorbance in the presence and absence of 
bacteria. (0) Strain Va 068/l; (0) Va 084; (m)Ty 7717. 
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NCA [ng added per well] 
Fig.3. Binding of E. coli strain Va 084 to NCA absorbed to a Fig.5. Binding of E. co/i strain Va 084 to immobilized NCA in the 
microtiter plate. Plates were coated with NCA amounts indicated on presence of increasing concentrations of a-methyl D- 
the abscissa. Further experimental details as in fig.2. mannopyranoside (250 ng NCA added per well). 
similarly inhibited by a-methyl D-mannopyranoside 
(fig.5). For reasons of lack of material, the remaining 
strains were not tested. As shown in fig.6, sugars other 
than a-methyl D-mannopyranoside did not inhibit bin- 
ding of strain Va 084 to CEA. 
3.3. Hemagglutination assay 
The E. coli strains were further investigated in a 
hemagglutination assay in which type 1 fimbriated 
bacteria show a mannose-sensitive agglutination. 
Following culture on DST agar for 18 h at 37”C, only 
strain Ty 7717 showed a mannose-sensitive agglutina- 
tion. The remaining two strains did not agglutinate. 
When these strains were further cultured under condi- 
tions optimal for the expression of type 1 fimbriae 
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Fig.4. Binding of different strains of E. co/i to immobilized CEA in 
the presence of increasing concentrations of a-methyl D- 
mannopyranoside (250 ng CEA added per well). (0) Strain 
Va 068/l; (0) Va 084; (m) Ty 7717. 
,l 1 10 100 
alpha-methyl D-mannopyranoside [mmol/l] 
(Luria broth, 48 h, 37”C), strain Va 68/l showed a 
faint and strain Va 084 showed a strong mannose- 
sensitive agglutination. 
3.4. Binding to deglycosylated CEA 
Microtiter plates were coated with deglycosylated 
CEA at amounts which resulted in MAb T84.1 binding 
comparable with native CEA. About lo-fold the 
amount of deglycosylated CEA was used for coating 
(2.5 pg per well). Compared with native CEA, a 
significantly lower binding is observed (table 1). The in- 
crease in non-specific binding was much more pro- 
nounced when the low titer crossreacting antibodies 
were used for the remaining strains. Due to the high 
background activity, enzyme immunoassays could not 
1 
n.i. GalNAcGlcNAc NeuAc (+)Fuc (-)Fuc Gal MeMan 
inhibitors [O.l mol/l] 
Fig.6. Binding of E. coli strain Va 084 to immobilized CEA in the 
presence of different inhibitors. n.i., no inhibitor; MeMan, a-methyl 
D-mannopyranoside. 
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Table 1 
Binding of E. coli strain Va 084 to native and deglycosylated CEAa 
Absorbance 
Native CEA Deglycosylated CEA 
Bacteria added 22.5 0.68 
No bacteria added 0.09 0.22 
a Amounts of antigens added per well were chosen to give 
comparable binding of monoclonal anti-CEA antibody T84.1. 
Native CEA = 250 ng per well; deglycosylated CEA = 2500 ng per 
well 
be evaluated. In the Acridine orange stain, strain 
Va 068/l did not bind, whereas some residual binding 
was observed with strain Ty 7717. 
4. DISCUSSION 
CEA is a highly glycosylated protein which is actively 
synthesized by normal colonic mucosa. In the colonic 
epithelium of infants and adults, CEA shows a polar 
membrane localization at the brush border cells lining 
the lumen of the large intestine [2,3]. Furthermore, the 
degree of expression of CEA-specific mRNA in normal 
colonic mucosa is comparable with colonic carcinoma 
cells j6], and normal colonic mucosa actively produces 
CEA in vivo [5] as well as in organ culture 161. NCA, 
a glycoprotein with extensive structural homology to 
CEA [7], is produced by normal granulocytes in a non- 
polar fashion [l 11. Since both the colonic epithelium 
and granulocytes are involved in the binding of 
bacteria, we considered bacterial recognition as a 
putative unifying concept for the biological function of 
both CEA and NCA. 
Here we provide evidence that different strains of E. 
cofi from human origin bind to immobilized CEA and 
NCA. The binding was dose dependent and saturable. 
Furthermore, the binding seems to be of relatively high 
avidity since binding plateaus were reached with 
amounts of CEA or NCA of less than 1 pug used to coat 
the wells of microtiter plates. In a hemagglutination 
test routinely used for the detection of type 1 fim- 
briated strains of E. cofi [ 131, one of the strains showed 
a mannose-sensitive agglutination after culture on DST 
agar. The remaining strains showed a mannose- 
sensitive agglutination only after being cultured under 
optimal conditions for the expression of type 1 fim- 
briae. At increasing amounts of a-methyl D- 
mannopyranoside, the binding of E. cofi to CEA and 
NCA was completely abolished. Since the E. coff 
strains did not bind to ConA and, in addition, their 
binding to deglycosylated CEA was abolished or 
significantly reduced, it is concluded that the bacteria 
bind to D-mannosyl residues in CEA and NCA [IS]. 
It is well established that colonic epithelial cells as 
well as granulocytes and macrophages bind type 1 fim- 
408 
briated bacteria via D-mannosyl residues 119-231. Our 
results suggest that CEA may be involved in the 
recognition of E. coff by human colonic epithelial cells, 
and that NCA may be involved in bacterial recognition 
by human granulocytes. Recently, Benchimol et al. [24] 
provided evidence that CEA may function as a 
homophilic cell adhesion molecule. However, the 
localisation of CEA at the colonic brush border cells in 
the colon of infants and adults is difficult to reconcile 
with this hypothesis. Similarly, a possible involvement 
of NCA in homophilic cell adhesion would be difficult 
to explain since NCA is produced by non-stimulated, 
non-adherent human granulocytes. Furthermore, the 
low conservation of the CEA family members during 
evolution 125,261 has to be taken into account when 
biological functions of these glycoproteins are con- 
sidered. Bacterial recognition would be compatible 
with the tissue distribution and the low conservation of 
CEA and NCA. Additional studies are being perform- 
ed in order to prove that CEA and NCA function as 
bacterial recognition molecules in coionic epithelia and 
granulocytes in vitro and in vivo. 
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